Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jun-ling Zhuang"'
Autor:
Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun‐ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Publikováno v:
Cancer Medicine, Vol 13, Iss 9, Pp n/a-n/a (2024)
Abstract Objective To evaluate the effectiveness, safety, and convenience of in‐class transition (iCT) from intravenous bortezomib‐based induction to ixazomib‐based oral regimens. Methods This retrospective real‐world study was conducted in 1
Externí odkaz:
https://doaj.org/article/baaecafcf2aa4b06bececf87315f3141
Autor:
Li Bao, Yu-Tong Wang, Peng Liu, Min-Qiu Lu, Jun-Ling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhen-Ling Li, Ying Yang, Zhen-Yu Yan, Hong-Mei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, He-Bing Zhou, Rong Fu, Yu-Ping Gong, Wen-Rong Huang, Yong-Qing Zhang
Publikováno v:
EClinicalMedicine, Vol 68, Iss , Pp 102431- (2024)
Summary: Background: Frail elderly patients with newly diagnosed multiple myeloma (NDMM) have inferior survival and less benefit from high-dose therapies. This prospective study aimed to investigate the efficacy, safety, and quality of life (QoL) of
Externí odkaz:
https://doaj.org/article/5f8ebc856a054016814d612ebfbeb0d8
Autor:
Li Bao, Ai‐Jun Liu, Bin Chu, Qian Wang, Yu‐Jun Dong, Min‐Qiu Lu, Lei Shi, Shan Gao, Yu‐Tong Wang, Li‐Fang Wang, Wen‐Ming Chen, Jun‐Ling Zhuang
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3101-3111 (2023)
Abstract Background The use of proteasome inhibitors (PIs), new immune modulators (IMiDs), and other new drugs, as well as high‐dose chemotherapy combined with autologous stem cell transplantation has considerably improved the survival of young pat
Externí odkaz:
https://doaj.org/article/3c209ddbaa4748f9be01e45bb442415d
Autor:
Xiao-hang Liu, Jia-yu Shi, Ding-ding Zhang, Fu-wei Jia, Xue Lin, Yan-lin Zhu, Jun-ling Zhuang, Li-gang Fang, Wei Chen
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Light-chain amyloidosis is a plasma cell disorder associated with poor outcomes, especially when the heart is involved. The characteristics of left atrial (LA) function and its prognostic implications in cardiac amyloidosis (CA) h
Externí odkaz:
https://doaj.org/article/c22c6e6ab7764c63afe1c9bfe352f3dc
Autor:
Li Bao, Yu-tong Wang, Jun-ling Zhuang, Ai-jun Liu, Yu-jun Dong, Bin Chu, Xiao-huan Chen, Min-qiu Lu, Lei Shi, Shan Gao, Li-juan Fang, Qiu-qing Xiang, Yue-hua Ding
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo use machine learning methods to explore overall survival (OS)-related prognostic factors in elderly multiple myeloma (MM) patients.MethodsData were cleaned and imputed using simple imputation methods. Two data resampling methods were impl
Externí odkaz:
https://doaj.org/article/9b6f7976ae5940de82c555f6cbb9143a
Autor:
Jun Ni, Miao Huang, Li Zhang, Nan Wu, Chun‐Xue Bai, Liang‐An Chen, Jun Liang, Qian Liu, Jie Wang, Yi‐Long Wu, Feng‐Chun Zhang, Shu‐Yang Zhang, Chun Chen, Jun Chen, Wen‐Tao Fang, Shu‐Geng Gao, Jian Hu, Tao Jiang, Shan‐Qing Li, He‐Cheng Li, Yong‐De Liao, Yang Liu, De‐Ruo Liu, Hong‐Xu Liu, Jian‐Yang Liu, Lun‐Xu Liu, Meng‐Zhao Wang, Chang‐Li Wang, Fan Yang, Yue Yang, Lan‐Jun Zhang, Xiu‐Yi Zhi, Wen‐Zhao Zhong, Yu‐Zhou Guan, Xiao‐Xiao Guo, Chun‐Xia He, Shao‐Lei Li, Yue Li, Nai‐Xin Liang, Fang‐Liang Lu, Chao Lv, Wei Lv, Xiao‐Yan Si, Feng‐Wei Tan, Han‐Ping Wang, Jiang‐Shan Wang, Shi Yan, Hua‐Xia Yang, Hui‐Juan Zhu, Jun‐Ling Zhuang, Ming‐Lei Zhuo
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1469-1488 (2021)
Abstract Perioperative adjuvant treatment has become an increasingly important aspect of the management of patients with non‐small cell lung cancer (NSCLC). In particular, the success of immune checkpoint inhibitors, such as antibodies against PD
Externí odkaz:
https://doaj.org/article/3dab770ad14a4eb394851fdb819f7bec
Autor:
Duo-Duo Zhao, Lu Zhang, Wen-Qin Li, Ming-Hui Duan, Jun-Ling Zhuang, Dao-Bin Zhou, Li-Shao Guo
Publikováno v:
Chinese Medical Journal, Vol 132, Iss 16, Pp 2002-2003 (2019)
Externí odkaz:
https://doaj.org/article/09266989bd6c46698203072bbfcfb5e3
Autor:
Li Bao, Ai‐Jun Liu, Bin Chu, Qian Wang, Yu‐Jun Dong, Min‐Qiu Lu, Lei Shi, Shan Gao, Yu‐Tong Wang, Li‐Fang Wang, Wen‐Ming Chen, Jun‐Ling Zhuang
Publikováno v:
Cancer Medicine. 12:3101-3111
The use of proteasome inhibitors (PIs), new immune modulators (IMiDs), and other new drugs, as well as high-dose chemotherapy combined with autologous stem cell transplantation has considerably improved the survival of young patients with multiple my
Autor:
YuanDong Shan, Ti Shen, Xianyong Jiang, Yong-Qiang Zhao, Shu-Jie Wang, Xin-xin Cao, Yan Zhang, Jun-Ling Zhuang, Jian Li, Wei Zhang, Jia-Qi Pan, Bing Han, Wei Wang, Miao Chen, Lu Zhang, Hao Cai, Ming-Hui Duan, Hui Li, Jun Feng, Nong Zou, C Yang, Xuan Wang, RongSheng Li, Tie-nan Zhu, Xiaozhou Ying, ChangWen Ge, YongJi Wu, Dao-Bin Zhou
Publikováno v:
SCIENTIA SINICA Vitae. 51:938-947
Autor:
Miao, Chen, Jun Ling, Zhuang
Publikováno v:
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. 43(1)
The self-renewal and differentiation of hematopoietic stem cells(HSCs)are highly regulated by epigenetic modification,in which histone acetylation can activate or silence gene transcription.Histone deacetylase inhibitors(HDACIs)can inhibit the activi